Advertisement
Screener

IRADIMED CORPORATION (IRMD) Research and Development Expense

2.8 / 5 stars · 68/120 Roast Me

IRADIMED CORPORATION Research and Development Expense

IRADIMED CORPORATION (IRMD) reported Research and Development Expense of $657.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:ResearchAndDevelopmentExpense · last filed 2026-07-31

  • IRADIMED CORPORATION research and development expense for the quarter ending 2026-06-30 was $657.00K, a 25.09% decline year-over-year.
  • IRADIMED CORPORATION research and development expense for the quarter ending 2026-03-31 was $956.00K, a 53.21% increase year-over-year.
  • IRADIMED CORPORATION research and development expense for the quarter ending 2025-12-31 was $799.03K, a 40.08% increase year-over-year.
  • IRADIMED CORPORATION research and development expense for the quarter ending 2025-09-30 was $674.36K, a 5.46% increase year-over-year.
  • IRADIMED CORPORATION research and development expense for fiscal 2025 was $2.98M, a 5.05% increase from fiscal 2024.
  • IRADIMED CORPORATION research and development expense for fiscal 2024 was $2.83M, a 0.93% decline from fiscal 2023.
  • IRADIMED CORPORATION research and development expense for fiscal 2023 was $2.86M, a 25.49% increase from fiscal 2022.
  • IRADIMED CORPORATION research and development expense for fiscal 2022 was $2.28M, a 19.58% increase from fiscal 2021.
Period endResearch and Development Expense 3 monthResearch and Development Expense 3 month as first filedResearch and Development Expense 6 monthResearch and Development Expense 6 month as first filedResearch and Development Expense 9 monthResearch and Development Expense 12 monthResearch and Development Expense 12 month as first filed
2026-06-30$657.00K
10-Q · filed 2026-07-31
$1.61M
10-Q · filed 2026-07-31
$2.41M
derived: sum of 3 quarters · filed 2026-07-31
$3.09M
derived: sum of 4 quarters · filed 2026-07-31
2026-03-31$956.00K
10-Q · filed 2026-05-01
$1.76M
derived: sum of 2 quarters · filed 2026-05-01
$2.43M
derived: sum of 3 quarters · filed 2026-05-01
$3.31M
derived: sum of 4 quarters · filed 2026-07-31
2025-12-31$799.03K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06
$1.47M
derived: sum of 2 quarters · filed 2026-03-06
$2.35M
derived: sum of 3 quarters · filed 2026-07-31
$2.98M
10-K · filed 2026-03-06
2025-09-30$674.36K
10-Q · filed 2025-11-03
$1.55M
derived: sum of 2 quarters · filed 2026-07-31
$2.18M
10-Q · filed 2025-11-03
$2.75M
derived: sum of 4 quarters · filed 2026-07-31
2025-06-30$877.00K
10-Q · filed 2026-07-31
$877.36K
10-Q · filed 2025-08-01
$1.50M
10-Q · filed 2026-07-31
$1.50M
10-Q · filed 2025-08-01
$2.07M
derived: sum of 3 quarters · filed 2026-07-31
$2.71M
derived: sum of 4 quarters · filed 2026-07-31
2025-03-31$624.00K
10-Q · filed 2026-05-01
$624.25K
10-Q · filed 2025-05-05
$1.19M
derived: sum of 2 quarters · filed 2026-05-01
$1.83M
derived: sum of 3 quarters · filed 2026-05-01
$2.63M
derived: sum of 4 quarters · filed 2026-05-01
2024-12-31$570.40K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06
$1.21M
derived: sum of 2 quarters · filed 2026-03-06
$2.01M
derived: sum of 3 quarters · filed 2026-03-06
$2.83M
10-K · filed 2026-03-06
$2.83M
10-K · filed 2025-03-06
2024-09-30$639.47K
10-Q · filed 2025-11-03
$1.44M
derived: sum of 2 quarters · filed 2025-11-03
$2.26M
10-Q · filed 2025-11-03
$2.91M
derived: sum of 4 quarters · filed 2025-11-03
2024-06-30$801.13K
10-Q · filed 2025-08-01
$1.62M
10-Q · filed 2025-08-01
$2.27M
derived: sum of 3 quarters · filed 2025-09-03
$2.73M
derived: sum of 4 quarters · filed 2025-09-03
2024-03-31$821.00K
10-Q · filed 2025-05-05
$3.83M
10-Q · filed 2024-05-02
$1.47M
derived: sum of 2 quarters · filed 2025-09-03
$1.92M
derived: sum of 3 quarters · filed 2025-09-03
$2.89M
derived: sum of 4 quarters · filed 2025-09-03
2023-12-31$650.43K
derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-09-03
$1.10M
derived: sum of 2 quarters · filed 2025-09-03
$2.06M
derived: sum of 3 quarters · filed 2025-09-03
$2.86M
10-K/A · filed 2025-09-03
2023-09-30$452.56K
10-Q · filed 2024-10-31
$1.41M
derived: sum of 2 quarters · filed 2024-10-31
$2.21M
10-Q · filed 2024-10-31
$5.02M
derived: sum of 4 quarters · filed 2024-10-31
2023-06-30$961.95K
10-Q · filed 2024-08-01
$1.76M
10-Q · filed 2024-08-01
$4.57M
derived: sum of 3 quarters · filed 2024-08-01
$5.06M
derived: sum of 4 quarters · filed 2024-08-01
2023-03-31$3.00M
10-Q · filed 2024-05-02
$793.72K
10-Q · filed 2023-05-04
$3.60M
derived: sum of 2 quarters · filed 2024-05-02
$4.10M
derived: sum of 3 quarters · filed 2024-05-02
$4.76M
derived: sum of 4 quarters · filed 2024-05-02
2022-12-31$604.74K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01
$1.10M
derived: sum of 2 quarters · filed 2024-03-01
$1.76M
derived: sum of 3 quarters · filed 2024-03-01
$2.28M
10-K · filed 2024-03-01
2022-09-30$491.64K
10-Q · filed 2023-11-03
$1.15M
derived: sum of 2 quarters · filed 2023-11-03
$1.67M
10-Q · filed 2023-11-03
$2.17M
derived: sum of 4 quarters · filed 2023-11-03
2022-06-30$662.60K
10-Q · filed 2023-08-03
$1.18M
10-Q · filed 2023-08-03
$1.68M
derived: sum of 3 quarters · filed 2023-08-03
$2.16M
derived: sum of 4 quarters · filed 2023-08-03
2022-03-31$519.10K
10-Q · filed 2023-05-04
$1.01M
derived: sum of 2 quarters · filed 2023-05-04
$1.49M
derived: sum of 3 quarters · filed 2023-05-04
$1.95M
derived: sum of 4 quarters · filed 2023-05-04
2021-12-31$494.85K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02
$975.55K
derived: sum of 2 quarters · filed 2023-03-02
$1.43M
derived: sum of 3 quarters · filed 2023-03-02
$1.91M
10-K · filed 2023-03-02
2021-09-30$480.70K
10-Q · filed 2022-11-03
$934.38K
derived: sum of 2 quarters · filed 2022-11-03
$1.41M
10-Q · filed 2022-11-03
$1.92M
derived: sum of 4 quarters · filed 2022-11-03
2021-06-30$453.68K
10-Q · filed 2022-08-05
$929.50K
10-Q · filed 2022-08-05
$1.44M
derived: sum of 3 quarters · filed 2022-08-05
$1.92M
derived: sum of 4 quarters · filed 2022-08-05
2021-03-31$475.82K
10-Q · filed 2022-05-06
$988.53K
derived: sum of 2 quarters · filed 2022-05-06
$1.47M
derived: sum of 3 quarters · filed 2022-05-06
$1.95M
derived: sum of 4 quarters · filed 2022-05-06
2020-12-31$512.72K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04
$989.59K
derived: sum of 2 quarters · filed 2022-03-04
$1.47M
derived: sum of 3 quarters · filed 2022-03-04
$1.90M
10-K · filed 2022-03-04
2020-09-30$476.88K
10-Q · filed 2021-11-05
$959.53K
derived: sum of 2 quarters · filed 2021-11-05
$1.39M
10-Q · filed 2021-11-05
$1.77M
derived: sum of 4 quarters · filed 2022-03-04
2020-06-30$482.65K
10-Q · filed 2021-08-06
$912.94K
10-Q · filed 2021-08-06
$1.29M
derived: sum of 3 quarters · filed 2022-03-04
$1.66M
derived: sum of 4 quarters · filed 2022-03-04
2020-03-31$430.28K
10-Q · filed 2021-05-07
$809.59K
derived: sum of 2 quarters · filed 2022-03-04
$1.18M
derived: sum of 3 quarters · filed 2022-03-04
$1.51M
derived: sum of 4 quarters · filed 2022-03-04
2019-12-31$379.31K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04
$748.84K
derived: sum of 2 quarters · filed 2022-03-04
$1.08M
derived: sum of 3 quarters · filed 2022-03-04
$1.43M
10-K · filed 2022-03-04
2019-09-30$369.53K
10-Q · filed 2020-11-06
$700.84K
derived: sum of 2 quarters · filed 2020-11-06
$1.05M
10-Q · filed 2020-11-06
$1.42M
derived: sum of 4 quarters · filed 2021-03-05
2019-06-30$331.31K
10-Q · filed 2020-08-06
$683.88K
10-Q · filed 2020-08-06
$1.05M
derived: sum of 3 quarters · filed 2021-03-05
$1.43M
derived: sum of 4 quarters · filed 2021-03-05
2019-03-31$352.57K
10-Q · filed 2020-05-07
$720.29K
derived: sum of 2 quarters · filed 2021-03-05
$1.09M
derived: sum of 3 quarters · filed 2021-03-05
$1.49M
derived: sum of 4 quarters · filed 2021-03-05
2018-12-31$367.71K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-05
$741.30K
derived: sum of 2 quarters · filed 2021-03-05
$1.14M
derived: sum of 3 quarters · filed 2021-03-05
$1.52M
10-K · filed 2021-03-05
2018-09-30$373.58K
10-Q · filed 2019-11-07
$769.57K
derived: sum of 2 quarters · filed 2019-11-07
$1.15M
10-Q · filed 2019-11-07
$1.50M
derived: sum of 4 quarters · filed 2020-03-06
2018-06-30$395.99K
10-Q · filed 2019-08-07
$775.81K
10-Q · filed 2019-08-07
$1.13M
derived: sum of 3 quarters · filed 2020-03-06
$1.51M
derived: sum of 4 quarters · filed 2020-03-06
2018-03-31$379.83K
10-Q · filed 2019-05-08
$729.38K
derived: sum of 2 quarters · filed 2020-03-06
$1.11M
derived: sum of 3 quarters · filed 2020-03-06
$1.56M
derived: sum of 4 quarters · filed 2020-03-06
2017-12-31$349.56K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-06
$732.26K
derived: sum of 2 quarters · filed 2020-03-06
$1.18M
derived: sum of 3 quarters · filed 2020-03-06
$1.72M
10-K · filed 2020-03-06
2017-09-30$382.70K
10-Q · filed 2018-11-07
$831.72K
derived: sum of 2 quarters · filed 2018-11-07
$1.37M
10-Q · filed 2018-11-07
$1.74M
derived: sum of 4 quarters · filed 2019-03-07
2017-06-30$449.01K
10-Q · filed 2018-08-08
$990.30K
10-Q · filed 2018-08-08
$1.35M
derived: sum of 3 quarters · filed 2019-03-07
$1.81M
derived: sum of 4 quarters · filed 2019-03-07
2017-03-31$541.29K
10-Q · filed 2018-05-08
$905.51K
derived: sum of 2 quarters · filed 2019-03-07
$1.36M
derived: sum of 3 quarters · filed 2019-03-07
$1.65M
derived: sum of 4 quarters · filed 2019-03-07
2016-12-31$364.22K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07
$821.35K
derived: sum of 2 quarters · filed 2019-03-07
$1.11M
derived: sum of 3 quarters · filed 2019-03-07
$1.35M
10-K · filed 2019-03-07
2016-09-30$457.13K
10-Q · filed 2017-11-06
$748.96K
derived: sum of 2 quarters · filed 2017-11-06
$983.29K
10-Q · filed 2017-11-06
$1.48M
derived: sum of 4 quarters · filed 2018-03-08
2016-06-30$291.82K
10-Q · filed 2017-08-04
$526.16K
10-Q · filed 2017-08-04
$1.03M
derived: sum of 3 quarters · filed 2018-03-08
$1.54M
derived: sum of 4 quarters · filed 2018-03-08
2016-03-31$234.34K
10-Q · filed 2017-05-05
$734.33K
derived: sum of 2 quarters · filed 2018-03-08
$1.25M
derived: sum of 3 quarters · filed 2018-03-08
$1.66M
derived: sum of 4 quarters · filed 2018-03-08
2015-12-31$500.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08
$1.02M
derived: sum of 2 quarters · filed 2018-03-08
$1.42M
derived: sum of 3 quarters · filed 2018-03-08
$1.76M
10-K · filed 2018-03-08
2015-09-30$518.56K
10-Q · filed 2016-11-04
$922.01K
derived: sum of 2 quarters · filed 2016-11-04
$1.26M
10-Q · filed 2016-11-04
$1.58M
derived: sum of 4 quarters · filed 2017-03-10
2015-06-30$403.45K
10-Q · filed 2016-08-05
$745.75K
10-Q · filed 2016-08-05
$1.06M
derived: sum of 3 quarters · filed 2017-03-10
$1.36M
derived: sum of 4 quarters · filed 2017-03-10
2015-03-31$342.30K
10-Q · filed 2016-05-06
$657.71K
derived: sum of 2 quarters · filed 2017-03-10
$961.17K
derived: sum of 3 quarters · filed 2017-03-10
$1.19M
derived: sum of 4 quarters · filed 2017-03-10
2014-12-31$315.41K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10
$618.87K
derived: sum of 2 quarters · filed 2017-03-10
$844.37K
derived: sum of 3 quarters · filed 2017-03-10
$1.07M
10-K · filed 2017-03-10
2014-09-30$303.46K
10-Q · filed 2015-11-10
$528.96K
derived: sum of 2 quarters · filed 2015-11-10
$753.27K
10-Q · filed 2015-11-10
$1.10M
derived: sum of 4 quarters · filed 2015-11-10
2014-06-30$225.50K
10-Q · filed 2015-08-11
$449.80K
10-Q · filed 2015-08-11
$795.42K
derived: sum of 3 quarters · filed 2015-08-11
$1.09M
derived: sum of 4 quarters · filed 2015-08-11
2014-03-31$224.30K
10-Q · filed 2015-05-11
$569.92K
derived: sum of 2 quarters · filed 2015-05-11
$869.34K
derived: sum of 3 quarters · filed 2015-05-11
$1.07M
derived: sum of 4 quarters · filed 2015-05-11
2013-12-31$345.62K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-23
$645.04K
derived: sum of 2 quarters · filed 2015-03-23
$849.46K
derived: sum of 3 quarters · filed 2015-03-23
$1.01M
10-K · filed 2015-03-23
2013-09-30$299.42K
10-Q · filed 2014-11-13
$503.85K
derived: sum of 2 quarters · filed 2014-11-13
$664.26K
10-Q · filed 2014-11-13
2013-06-30$204.42K
10-Q · filed 2014-08-14
$364.83K
10-Q · filed 2014-08-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
TANDEM DIABETES CARE INC (TNDM)United States$1.059B-16.57
ARTIVION, INC. (AORT)United States$1.123B-345.09
PROCEPT BioRobotics Corp (PRCT)United States$1.001B-11.77
Beta Bionics, Inc. (BBNX)United States$0.979B-9.66
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)United States$1.234B-193.02
SpyGlass Pharma, Inc. (SGP)United States$0.925B
SI-BONE, Inc. (SIBN)United States$0.830B-49.82
MIMEDX GROUP, INC. (MDXG)United States$0.687B89.92
Alphatec Holdings, Inc. (ATEC)United States$1.531B-12.14
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)United States$1.535B-9.02